SLP's Q3 Earnings Top, Sales Up Y/Y, Stock Gains Despite Lowered View

  • Simulation Plus' fiscal Q3 2025 earnings surge 67% on Pro-ficiency gains, but a cut in 2025 outlook shows hurdles in biosimulation and services.